Follow-up advice on conditional inclusion of entrectinib (Rozlytrek®)

de Vries S, Wijma S
Record ID 32018002687
Project Status: Completed
Year Published: 2021
English language abstract: An English language summary is available
Publication Type: Other
Country: The Netherlands
MeSH Terms
  • Neoplasms
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • entrectinib (Rozlytrek┬«)
Organisation Name: The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address: Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name: Timon Sibma
Contact Email:
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.